Texas vs Washington on USAspending: $72.7B vs $7.3B
Texas’s stacked USAspending.gov obligation stock is $72.7B; Washington’s is $7.3B. Washington files that smaller stock on 7,958,180 residents against Texas’s 31,290,831, which is why spending per capita is $73.46 versus $686.1. Award volume favors Texas, 530,634 against 236,821. FY2026 is $21.5B in Texas versus $584.6M in Washington. The figures are obligations, not outlays.
Key figures
- Texas $72.7B vs Washington $7.3B in stacked USAspending obligations.
- Per capita $686.1 vs $73.46 on 31,290,831 vs 7,958,180 residents.
- Awards 530,634 vs 236,821; FY2026 $21.5B vs $584.6M.
- Top industries: pharmaceutical preparation manufacturing in Texas; commercial building construction in Washington.
- Figures are USAspending.gov obligations, not Treasury outlays.
A Pacific $7.3B file with a cool $73.46 ratio
Texas’s $72.7B stacked stock sits well above Washington’s $7.3B. Census population leans Texas: 31,290,831 versus 7,958,180. Intensity is the ranking that opens widest. $73.46 per capita in Washington is far cooler than Texas’s $686.1. Cite those packet ratios beside the Census counts; they are not a second copy of $72.7B and $7.3B.
Award volume follows Texas, 530,634 versus 236,821. The row gap is milder than the dollar gap. Row count is not average award size. Cite USAspending.gov. Do not invent a mean from 530,634 or 236,821.
Commercial building construction versus pharmaceutical preparation
Washington’s lead NAICS is commercial and institutional building construction. Texas’s is pharmaceutical preparation manufacturing. A construction peak is a first read on Washington’s $7.3B mix. A drug-manufacturing peak is a first read on Texas’s $72.7B mix. Buildings and pharmaceuticals are not the same label.
The 236,821 Washington awards and 530,634 Texas awards include many actions outside those two industries. Use the Texas and Washington state hubs for agencies and recipients. Both peaks are USAspending.gov obligation mixes. Outlays are not in the packet.
Washington’s 236,821 awards and $584.6M FY2026 slice sit on 7,958,180 residents. Texas’s 530,634 awards and $21.5B sit on 31,290,831. Commercial and institutional building construction versus pharmaceutical preparation manufacturing remains the mix contrast on $7.3B and $72.7B. $73.46 versus $686.1 is the intensity ranking. Cite USAspending.gov.
FY2026: Texas’s $21.5B versus Washington’s $584.6M
Fiscal year 2026 obligations are $21.5B in Texas and $584.6M in Washington. Recency preserves Texas’s stacked dollar lead. Treat the year as a recency slice of obligations, not as Treasury cash already paid.
Do not divide $21.5B or $584.6M by 530,634 or 236,821 all-years awards. Spending per capita of $686.1 and $73.46 already sits beside Census counts of 31,290,831 and 7,958,180. Cite USAspending.gov for both cuts.
What $73.46 looks like on 7,958,180 residents
Washington’s $7.3B on 7,958,180 people produces $73.46 per capita, much cooler than Texas’s $686.1 on 31,290,831. The construction peak sits on that cooler ratio and on 236,821 awards. The $584.6M FY2026 slice is the recency cut on the smaller stock.
Texas’s pharmaceutical peak, 530,634 awards, and $21.5B latest-year amount remain the larger file. Read a Pacific Northwest construction peak against a national-scale pharmaceutical file. Keep every dollar figure labeled as a USAspending.gov obligation.
How to read Texas versus Washington
Read Texas first on stacked dollars ($72.7B vs $7.3B), population (31,290,831 vs 7,958,180), awards (530,634 vs 236,821), spending per capita ($686.1 vs $73.46), and FY2026 ($21.5B vs $584.6M). Note pharmaceutical preparation manufacturing versus commercial and institutional building construction.
The comparison hub holds the tables. The Texas and Washington hubs hold agencies and recipients. Outlays are a different series. Cite USAspending.gov. Keep $686.1 and $73.46 labeled as Census-based obligation ratios.
A Pacific construction file with a $73.46 ratio
Washington’s commercial and institutional building construction peak sits on $7.3B, 7,958,180 residents, 236,821 awards, $73.46 per capita, and $584.6M in FY2026. Texas’s pharmaceutical preparation manufacturing peak sits on $72.7B, 31,290,831 residents, 530,634 awards, $686.1, and $21.5B. Award volume is closer than the dollar ranking. Intensity is not. $73.46 versus $686.1 is a wide gap on two large Census files.
Cite USAspending.gov. A large Pacific Census file can still sit with a cool obligation ratio. Outlays are not in the packet. The comparison hub holds the tables. The Texas and Washington hubs hold agencies and recipients. Do not invent a mean from 530,634 or 236,821.
Questions
- Does Texas or Washington have more federal spending?
- Texas leads stacked USAspending.gov obligations $72.7B to Washington’s $7.3B, spending per capita $686.1 to $73.46, awards 530,634 to 236,821, and FY2026 obligations $21.5B to $584.6M. Population is 31,290,831 in Texas and 7,958,180 in Washington.
- What industries lead in Texas and Washington?
- Texas’s top industry is pharmaceutical preparation manufacturing. Washington’s is commercial and institutional building construction. Those labels are the largest NAICS slices on $72.7B and $7.3B. Award counts are 530,634 in Texas and 236,821 in Washington.
- Why is Washington’s per-capita figure so much lower?
- The packet reports $73.46 per capita in Washington on 7,958,180 residents and $686.1 in Texas on 31,290,831. Stacked stocks are $7.3B versus $72.7B. These figures are USAspending.gov obligations, not outlays. A large Census file can still sit with a cool ratio.
- Are Texas vs Washington figures Treasury outlays?
- No. The $72.7B and $7.3B totals, and FY2026 amounts of $21.5B and $584.6M, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($686.1 vs $73.46) uses Census population where present. This packet does not publish outlays or average award size.
State comparison from SpendingVault aggregates of USAspending obligations. Per-capita uses Census population where present.